SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029551
Filing Date
2019-08-07
Accepted
2019-08-06 20:21:34
Documents
93
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xfor-10q_20190630.htm 10-Q 2763407
2 EX-31.1 xfor-ex311_7.htm EX-31.1 8697
3 EX-31.2 xfor-ex312_6.htm EX-31.2 8678
4 EX-32.1 xfor-ex321_8.htm EX-32.1 21689
  Complete submission text file 0001564590-19-029551.txt   11444542

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xfor-20190630.xml EX-101.INS 2685599
6 XBRL TAXONOMY EXTENSION SCHEMA xfor-20190630.xsd EX-101.SCH 94992
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xfor-20190630_cal.xml EX-101.CAL 61911
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xfor-20190630_def.xml EX-101.DEF 311758
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE xfor-20190630_lab.xml EX-101.LAB 640889
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xfor-20190630_pre.xml EX-101.PRE 511677
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 191003600
SIC: 2836 Biological Products, (No Diagnostic Substances)